Skip to content

Clinical trials

Terminated Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Terminated Clear all

326 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
200111
20023
20032
200415
200519
200616
200713
200829
200917
201023
201114
201215
201313
201411
201515
201613
201710
201811
201912
202016
202111
202210
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated326

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)32
Gilead Sciences18
M.D. Anderson Cancer Center18
Masonic Cancer Center, University of Minnesota13
TG Therapeutics, Inc.11
Fred Hutchinson Cancer Center7
OHSU Knight Cancer Institute6
City of Hope Medical Center5
H. Lee Moffitt Cancer Center and Research Institute5
Novartis Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell326
Lymphoma, Non-Hodgkin132
Lymphoma, Follicular118
Lymphoma, Mantle-Cell109
Precursor Cell Lymphoblastic Leukemia-Lymphoma107
Lymphoma, Large B-Cell, Diffuse104
Lymphoma, B-Cell, Marginal Zone100
Leukemia86
Lymphoma82
Hodgkin Disease78

Trials

Showing 26 to 50 of 326. Each trial links to its page on Pharma Observatory.

226 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.